Science and Technology Development Journal

An official journal of Viet Nam National University Ho Chi Minh City, Viet Nam since 1997

Skip to main content Skip to main navigation menu Skip to site footer

 Section: HEALTH SCIENCES

HTML

1137

Total

387

Share
Bacterial pathogens causing community–acquired pneumonia in hospitalized adult patients with and without chronic obstructive pulmonary disease






 Open Access  

Downloads

Download data is not yet available.

Abstract

Background: Community-acquired pneumonia (CAP) is a common infection that often occurs in older adults who may have chronic obstructive pulmonary disease (COPD), a common respiratory condition characterized by airflow limitation. Chronic obstructive pulmonary disease and community-acquired pneumonia usually cause the same symptoms as respiratory tract infections, but they have potential differences in microbial etiology. This study aimed to assess the potential of bacterial pathogens in hospitalized CAP patients with and without COPD as well as bacterial combinations and to examine different rates of bacterial pathogens causing CAP between patients with and without COPD.


Methods: This is a multicenter study conducted on hospitalized adult patients with community-acquired pneumonia with and without chronic obstructive pulmonary disease at the Respiratory Department of Nguyen Tri Phuong Hospital, Nhan Dan Gia Dinh Hospital and University Medical Center from 04/2021 to 03/2023. Collected sputum samples that were assessed as reliable (according to the Bartlett scale) were included in the study. The sputum samples were transported to Nam Khoa Company’s laboratory to carry out multiplex real-time PCR with King Fisher FLEX as the nucleic acid extraction instrument and CFX 96TM of Bio-Rad as the real-time PCR system. For statistical analysis, data collection was solved by SPSS 20.0 software and Microsoft Excel 2020.


Results: Among 341 CAP patients, there were 91 patients (26.7%) with COPD, in which 89 patients were detected with a bacterial infection. The positive rates were 97.8% in CAP patients with COPD and 54.0% in CAP patients without COPD (p<0.001). Bacterial pathogens that caused CAP in patients with and without COPD extended to gram-negative bacilli. The top 5 bacterial pathogens in CAP patients with and without COPD were Acinetobacter baumannii (25.3% & 14.4%), Haemophilus influenzae (23.1% & 10.8%), Klebsiella pneumoniae (22.0% & 17.2%), Streptococcus pneumoniae (20.9% & 14.8%) and Escherichia coli (13.2% & 8.4%), in which the different percentages of Acinetobacter baumannii and Haemophilus influenzae were statistically significant (p<0.05). Pseudomonas aeruginosa was found at a low frequency (1.1% & 5.6%). Atypical bacteria were detected for only Mycoplasma at low frequencies (4.4% & 6.8%) and often occurred as a combined bacterium. Klebsiella pneumoniae and Escherichia coli in CAP with COPD and Acinetobacter baumannii and Escherichia coli in CAP without COPD were not often defined as the primary bacteria alone. More than one bacterial pathogen was commonly found in the sputum of CAP patients with and without COPD.


Conclusions: CAP patients with COPD occur at a rate of 26.7%. Bacterial pathogens were detected in 97.8% of CAP patients with COPD and 54.0% of CAP patients without COPD (p<0.001), and they extended to gram-negative bacilli. The top 5 bacterial pathogens in the two groups were the same with different rates, in which the different rates of Acinetobacter baumannii and Haemophilus influenzae were statistically significant (p<0,05). Pseudomonas aeruginosa is found less commonly, although it is important because of its critical antibiotic resistance and mortality. Atypical bacteria are detected for only Mycoplasma in low frequency, and it often occurs as a combined bacterium. Klebsiella pneumoniae and Escherichia coli in CAP with and without COPD are rarely or not defined as the primary bacteria alone. More than one bacterial pathogen is commonly found in the sputum of CAP patients with and without COPD.

INTRODUCTION

Community-acquired pneumonia (CAP) is a common infection that occurs in any individual at any age, especially in older adults, who may have chronic obstructive pulmonary disease (COPD), a common respiratory condition characterized by abnormalities of the airways 1 . Chronic obstructive pulmonary disease is also one of the leading causes of morbidity and mortality worldwide. Recent projections predict that by 2030, it will be the fourth main cause of death and the seventh cause of the global burden of infectious disease 2 . Chronic obstructive pulmonary disease and community-acquired pneumonia usually cause the same symptoms as respiratory tract infections, but they have potential differences in microbial etiology 1 , 3 . Otherwise, as a consequence of its chronicity, chronic obstructive pulmonary disease causes high resource utilization with clinician office visits and frequent hospitalization due to acute exacerbation for treatment, especially with antibiotics for microbial infection 4 , 5 , 6 . Hospitalized community-acquired pneumonia, with or without chronic obstructive pulmonary disease, is hard to identify the pathogenic bacteria since the primary specimen is often taken from patients’ sputum, which is at high risk of contamination when passing through the oropharynx. Therefore, traditional cultural techniques are limited due to many difficulties 7 : most patients have taken antibiotics, and the bacteria could still be alive in the alveola or bronchial epithelia fluid but could have already perished in the sputum. In addition, several subjective reasons from the laboratory could reduce the ability to successfully culture pathogens, such as a lack of adequate environment to isolate the primary pathogens while they are often difficult to culture, samples that cannot be cultured as quickly as possible to increase the chance of detecting pathogens, inexperienced technicians hence unable to choose the right pathogen colonies on the isolating agar plates, or the sample was not assessed for its reliability to remove nonsputum fluid such as viscous mucus in the oropharynx prior to the isolation procedure. To overcome such difficulties, multiplex real-time PCR was used as the optimal technique, which has also proven its high sensitivity and specificity. Multiplex real-time PCR can not only simultaneously detect the specific nucleic acid sequence of the bacteria but also calculate the number of copies to allow the identification of bacterial agents as pathogens.

The aims of this study were (1) to assess the potential of bacterial pathogens in hospitalized patients with community-acquired pneumonia with and without chronic obstructive pulmonary disease as well as bacterial combinations. (2) To examine different rates of bacterial pathogens that caused community-acquired pneumonia between patients with and without chronic obstructive pulmonary disease.

METHODS

This is a multicenter study conducted on hospitalized adult patients with community-acquired pneumonia with and without chronic obstructive pulmonary disease at the Respiratory Department of Nguyen Tri Phuong Hospital, Nhan Dan Gia Dinh Hospital and University Medical Center from 04/2021 to 03/2023. Collected sputum samples that were assessed as reliable (according to the Bartlett scale) were included in the study. The samples were transported to Nam Khoa Company’s laboratory to carry out multiplex real-time PCR in which DNARNAprep-MAGBEAD (from Nam Khoa Co.) and King Fisher FLEX (from Thermo) were used for the nucleic acid extraction step; multiplex real-time PCR mixes specific for bacterial pathogens causing pneumonia (Nam Khoa Co.) and the CFX 96 TM real-time PCR machine (from Bio-Rad) were used for the amplification step to detect and quantify the target nucleic acid by real-time PCR. Bacterial agents were identified as pathogens when their quantitative measurement was ≥ 100.000 copies. For atypical bacteria, the detected bacteria were identified as pathogenic agents regardless of their quantity. Bacteria with the highest quantity were considered primary pathogens, and others with lower quantities were considered combined agents 7 , 8 . For statistical analysis, data collection was performed using SPSS 20.0 and Microsoft Excel 2020 software.

For ethical considerations, we only practiced in the laboratory to detect bacterial pathogens causing community-acquired pneumonia due to the requirement of clinical doctors. The researcher had no contact with patients or clinical doctors for requirements. Our research was approved by the Independent Ethical Committee (IEC) of the University of Medicine and Pharmacy HCMC at Decision No 330/DHYD-HDDD, issue: June 14 th , 2019.

RESULTS

There were 341 sputum samples from hospitalized adult patients with community-acquired pneumonia that matched the inclusion criteria of this study. The demographic data and the results of bacterial detection by multiplex real-time PCR are shown in Table 1 .

Table 1 Demographic data and bacterial detection by MPL-rPCR

Table 1 shows that the incidence of community-acquired pneumonia patients with COPD was only 26.7% among the 341 CAP patients. Male sex accounted for 90.1% of patients with COPD and 52.4% of patients without COPD, and the rates of bacterial pathogens detected in patients with COPD and without COPD were 97.8% and 54.0%, respectively. This difference was statistically significant (p<0.001).

In 91 CAP patients with COPD, 89 patients were detected with bacterial pathogens. The positive rate was 97.8%. The bacterial pathogens causing CAP in 91 patients with COPD detected by multiplex real-time PCR are shown in Table 2 .

Table 2 The proportion of bacterial pathogens in CAP patients with COPD

The data from Table 2 show that bacterial pathogens that caused CAP in patients with COPD extended to gram-negative bacilli, in which Acinetobacter baumannii was at the highest rate (25.3%), followed by Haemophilus influenzae (23.1%) and Klebsiella pneumoniae (22.0%). Pseudomonas aeruginosa was found to be less common (1.1%). Mycoplasma , an atypical bacterium, was isolated in 4.4%. In many cases, more than one bacterial pathogen was isolated from the sputum of CAP patients with COPD.

Among 250 CAP patients without COPD, 135 patients were detected with bacterial pathogens. The positive rate was 54.0%. The bacterial pathogens detected by multiplex real-time PCR of the sputum samples collected from 250 CAP patients without COPD are shown in Table 3 .

Table 3 The proportion of bacterial pathogens in CAP patients without COPD

According to Table 3 , the list of bacterial pathogens that caused CAP in patients without COPD extended to gram-negative patients, in which Klebsiella pneumoniae was at the highest rate (17.2%), followed by Streptococcus pneumoniae (14.8%) and Acinetobacter baumannii (14.4%). Mycoplasma , an atypical bacterium, was found at a rate of 6.8%. In many cases, more than one bacterial pathogen was isolated from the sputum samples of CAP patients without COPD.

From the list of bacterial pathogens that caused CAP in patients with and without COPD, we selected the top 5 bacterial pathogens, which are shown in Table 4 .

Table 4 The top 5 bacterial pathogens causing CAP with or without COPD

Data from Table 4 show that the top 5 bacterial pathogens detected in CAP with and without COPD were the same however, their percentages in CAP with COPD were higher than those in CAP without COPD, in which the different percentages of Acinetobacter baumannii and Haemophilus influenzae were statistically significant (p < 0.05). Based on the copy number of the bacterial pathogens detected by multiplex real-time PCR, we defined the causative bacteria as the primary bacterial pathogen (the one with the highest copy number) and the combined bacterial pathogens (the one with the lowest copy number). Table 5 shows the combination of the top 5 bacterial pathogens detected by multiplex real-time PCR in 91 CAP patients with COPD and 250 CAP patients without COPD.

Table 5 The combination of the top 5 bacterial pathogens causing CAP with and without COPD

The data from Table 5 show that Escherichia coli occurred as the only combined bacteria in CAP patients with COPD, whereas Streptococcus pneumoniae and Haemophilus influenzae were detected commonly as primary bacteria alone in CAP patients without COPD.

DISCUSSION

In our study, the rate of CAP patients with COPD aged over 60 years was 78.0%, and the rate of male sex was 90.1%. These rates were similar to the reports by previous authors: Julio A., Ramirez and Rodrigo Cavallazzi (74.0% and 90.5%) 9 , Xue-Jun Li MD (75.3% and 71.0%) 10 , Joan Gómez-Junyent (79.9% and 90.5%) 11 , Dang Quynh Giao Vu, Le Thuong Vu (87.6% and 88.5%) 12 . There has been a significant increase in the age of CAP patients with and without COPD over the past decade, probably because of the increasing age of the population 13 . Community-acquired pneumonia patients with COPD had a prevalence rate of 26.7% (91/341), similar to the reports by Sogaard M (33.3%) 14 , Amir Sharafkhaneh (32.7%) 15 , Joan Gómez-Junyent (23.9%) 11 and Pascual-Guardia (21%) 16 .

Although COPD was only 26.7% in total CAP patients, the proportion of bacterial pathogens (positive rate) was 97.8%, while in CAP patients without COPD, the proportion was 54.0%. There was a statistically significant difference in the pathogen detection rate between these two groups of patients (p < 0.001). The pathogen detection rate in CAP patients with COPD by Ly Khanh Van and Pham Hung Van was 69.0% 17 , lower than that in our research (97.8%). The pathogen detection rates in CAP patients without COPD were 53% by Xue-Jun Li MD 10 and 53.8% by Dao Thi My Ha 18 , similar to our study (54.0%). Some previous reports indicated that the microbial etiology of CAP in patients with COPD may differ from that of CAP patients without COPD, and more than one bacterial pathogen was found in the sputum of CAP patients with and without COPD 11 , 13 , 19 , 20 , 21 .

In CAP patients with COPD, Acinetobacter baumannii was the most prevalent at 25.3%, while Streptococcus pneumoniae was only at 20.9% ( Table 4 ). In contrast, some previous reports indicated that in CAP patients with COPD, Streptococcus pneumoniae was the most prevalent at 39.4% 11 , 45.7% 22 , 32.6% 23 and 28.8% 24 . Other previous studies reported that Streptococcus pneumoniae occurred less frequently than gram-negative bacilli in recent days, but it still plays a role in causing CAP in adult patients 3 , 11 , 13 , 21 , 22 , 25 , 26 . In our study, bacterial pathogens causing CAP in patients with and without COPD extended to gram-negative bacteria more than gram-positive bacteria ( Table 2 , Table 3 ), similar to reports by previous authors 9 , 12 , 14 , 21 , 27 . Perhaps gram-negative bacilli, especially Acinetobacter baumannii and Klebsiella pneumoniae , have increased in CAP patients with COPD as well as without COPD in recent days.

In our study, the top 5 bacterial pathogens in CAP with and without COPD were the same as Acinetobacter baumannii , Haemophilus influenzae, Klebsiella pneumoniae, Streptococcus pneumoniae , and Escherichia coli but at different prevalence rates, in which the different percentages of Acinetobacter baumannii and Haemophilus influenzae were statistically significant (p < 0.005), similar to the report by previous authors 3 , 10 , 11 , 23 .

In this study, Pseudomonas aeruginosa causing CAP in patients with and without COPD was counted at rates of 1.1% and 5.6%, respectively (Tables 2, 3). Although Pseudomonas aeruginosa was counted at a low rate, it was important because of risk factors such as antibiotic resistance, mortality and outcomes 10 , 13 , 17 , 27 , 28 , 29 , 30 , 31 . Furthermore, previous studies have reported that Pseudomonas aeruginos a played an important role in CAP patients with severe COPD who were elderly and associated with regular oral corticosteroid therapy 31 , 32 , 33 .

Atypical bacteria were detected for only Mycobacteria at low frequency in CAP patients with COPD (4.4%) and without COPD (6.8%), similar to a previous report by De-Shun Liu (6.5%) 3 . Some recent studies have suggested that atypical bacteria in CAP patients are rare and often occur as combined bacteria, along with typical bacterial pathogens 34 , 35 , 36 .

In the bacterial combination, our study showed that K. pneumoniae , A. baumannii , H. influenzae , S. pneumoniae and E. coli can play a role as primary bacterial pathogens as well as combined bacterial pathogens in which K. pneumoniae and E. coli were rarely or not found as the primary bacteria alone in CAP with and without COPD.

CONCLUSIONS

Among 341 CAP patients, 91 patients had COPD (26.7%), 97.8% had bacterial pathogens detected by multiplex real-time PCR, and the positive rate in CAP patients without COPD was 54.0% (p < 0.001). Bacterial pathogens causing CAP in patients with and without COPD extend to gram-negative bacilli. The top 5 bacterial pathogens in the two groups were the same with different rates, in which the different rates of Acinetobacter baumannii and Haemophilus influenzae were statistically significant (p < 0.05). Pseudomonas aeruginosa is less common, although it is important because of its critical antibiotic resistance and mortality. Atypical bacteria are detected for only Mycoplasma at low frequency and often occur as a combined bacterium. Klebsiella pneumoniae and Escherichia coli in CAP with and without COPD are rarely or not defined as the primary bacteria alone. More than one bacterial pathogen is commonly found in the sputum of CAP patients with and without COPD.

Abbreviations

CAP : Community-acquired pneumonia

CMV : Cytomegalo virus

COPD : Chronic Obstructive Pulmonary Disease

EBV : Epstein-Barr virus

IEC : Independent Ethics Committee

MRSA : Methicillin-Resistant Staphylococcus aureus

MRSE : Methicillin-resistant Staphylococcus epidermidis

MSSA : Methicillin-susceptible Staphylococcus aureus

ACKNOWLEDGEMENT

None.

CONFLICT OF INTEREST

The authors declare that there is no conflict of interest.

AUTHORS’ CONTRIBUTION

Conceptualization, writing original protocol: L.K.V and L.V.X.; investigation writing – original draft, and collecting data: L.K.V.; protocol review: L.V.X.; formal analysis: L.K.V; writing – review and editing: L.K.V, L.V.X and P.H.V; All authors, including L.K.V, L.V.X and P.H.V revised the manuscript and agreed to the final version before submission.

References

  1. Agustí A, Celli B. R, Criner G. J, Halpin D, Anzueto A, Barnes P, ... and Vogelmeier C. F. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Archivos de Bronconeumologia. 2023:223-248. . ;:. PubMed Google Scholar
  2. Sullvan J, Pravosud V, Mannino DM, et al. National and State estimates of COPD morbidity and mortality - United States, 2014-2015. Chronic Obs Pulm Dis. 2018;5:324. . ;:. PubMed Google Scholar
  3. De-Shun Liu, Xiu-Di Han, Xue-Dong Liu. Current status of community-acquired pneumonia in patients with chronic obstructive pneumonary disease. Chinese Medical Journal. May 5, 2018;131(9):1086-1091. . ;:. PubMed Google Scholar
  4. Meilan King Han, Mark T Dransfield, Fernando J Martinez. Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis and staging. Radiology. 2023;295:218. . ;:. Google Scholar
  5. Maselli DJ, Hardin M, Christenson SA, et al. Clinical approach to the therapy of asthma-COPD overlap. Chest. 2019:155-168. . ;:. PubMed Google Scholar
  6. Cilli A. Community-acquired pneumonia in patients with chronic obstructive pulmonary disease. Curr Infect Dis Rep. 2015;17:444. . ;:. PubMed Google Scholar
  7. Pham HV. Technique for taking and examining clinical microbilogy of different specimens. Teaching materials for microbiology students. 2005:54-62. . ;:. Google Scholar
  8. Le TD, Pham HV. Pathogen of community-acquired pneumoniae. Journal of Medicine Ho Chi Minh. 2010;14(2): 56-60. . ;:. Google Scholar
  9. Julio A, Ramirez, Rodrigo Cavallazzii. Community-acquired pneumoniae pathogenesis in patients with chronic obstructive pulmonary disease. University of Louisville Journal of Respiratory Infections. 2019. . ;:. Google Scholar
  10. Xue-Jun Li MD, Qi Li MD, Liang-Ji Si MD and Qiao Ying Yuan. Bacteriological differences between COPD exacerbation and community-acquired pneumonia. Respiratory care. November 2011;56(11):1818-1824. . ;:. PubMed Google Scholar
  11. Joan Gómez-Junyent, Carolina Garcia-vidal, Diego Viasus and et al. Clinical features, etiology and outcomes of community-acquired pneumonia in patients with choronic obstructive pulmonary disease. Plos one. August 2014;9(8):e105854:1-10. . ;:. PubMed Google Scholar
  12. Dang Quynh Giao Vu, Le Thuong Vu. Clinical characteristics and outcomes of pneumonia in patients with chronic obstructive palmonary disease. Medical News Journal. 2017;9:63-69. . ;:. Google Scholar
  13. Cillóniz C, Cardozo C, and García-Vidal C. Epidemiology, pathophysiology, and microbiology of community-acquired pneumonia. Ann Res Hosp. 2018;2(1):1-11. . ;:. Google Scholar
  14. Sogaard M, Madsen M, Lokke A et al. Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia. Int J chron obstruct pulmo Dis. 2016;11:455-465. . ;:. PubMed Google Scholar
  15. Amir Sharafkhaneh et al. Mortality in patients admitted for concurrent COPD exacerbation and pneumonia. Journal of chronic obstructive pulmonary disease. 2016:1-7. . ;:. PubMed Google Scholar
  16. Pascual-Guardia S, Amati F, Marin-Corral et al. Bacterial patterns and empiric antibiotic use in COPD patients with community-acquired pneumonia. Archivos de Bronconeumologia. 2023;59(2):90-100. . ;:. PubMed Google Scholar
  17. Ly Khanh Van, Pham Hung Van. Pathogens causing hospitalized community-acquired pneumonia in COPD patients. Journal of Medicine Ho Chi Minh city. 2018;22(2):210-215. . ;:. Google Scholar
  18. Dao Thi My Ha. Microbial etiologies of community -acquired pneumonia and healthcare -acquired pneumonia are detected by real-time pcr of sputum. Respiratory Association HCMC. 2019:72-81. . ;:. Google Scholar
  19. Cillóniz C, Ewig S, Polverino E, Marcos M. A, Esquinas C, Gabarrús A, ... and Torres A. Microbial etiology of community-acquired pneumonia and its relation to severity. Thorax. 2011;66(4):340-346. . ;:. PubMed Google Scholar
  20. Jain S, Self W. H, Wunderink R. G, Fakhran S, Balk R, Bramley A. M, ... and Finelli L. Community-acquired pneumonia requiring hospitalization among US adults. New England Journal of Medicine. 2015;373(5):415-427. . ;:. PubMed Google Scholar
  21. Braeken D, Franssen F, Schütte H, Pletz M, Bals R, Martus P and Rohde G. Microbial etiology of community-acquired pneumonia and it is relation with ICS use in patients with COPD-Results from the German competence network CAPNETZ. European Respiratory Journal. 2014;44(58):24-76. . ;:. Google Scholar
  22. Costa M. I, Cipriano A, Santos F. V, Valdoleiros S. R, Furtado I, Machado A, ... and Bastos H. N. Clinical profile and microbiological etiology diagnosis in adult patients hospitalized with community-acquired pneumonia. Pulmonology. 2022;28(5):358-367. . ;:. PubMed Google Scholar
  23. Restrepo M. I, Mortensen E.M, Pugh J. A and Anzueto A. COPD is associated with increased mortality in patients with community-acquired pneumonia. European Respiratory Journal. 2006;28(2):346-351. . ;:. PubMed Google Scholar
  24. Alica Edin, Susanne Granholm, Satu Koskiniemi Allard, Andes Sjöstedt and Andes Johansson. Development and laboratory evaluation of a real-time PCR assay for detecting viruses and bacteria of relevance for community-acquired pneumonia. The Journal of Molecular Diagnostics. 2015;17(3):315-324. . ;:. PubMed Google Scholar
  25. Arturo Huerta et al. Pneumonic and nonpneumonic exacerbations of COPD: Inflamatory response and clinical characteristics. 2013;144(4):1134-1142. . ;:. PubMed Google Scholar
  26. Carugati M, Aliberti S, Reyes L. F, Sadud R. F, Irfan M, Prat C, ... and Restrepo M. I. Microbiological testing of adults hospitalized with community-acquired pneumonia: an international study. ERJ open research. 2018;4(4). . ;:. PubMed Google Scholar
  27. Bordon J, Slomka M, Gupta R, Furmanek S, Cavallazzi R, Sethi S, Niederman M, Ranirez JA. University of Louiville pneumonia study group. Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology and outcomes. Clinical microbiology and infection. Jun 26, 2019. . ;:. Google Scholar
  28. Liapikou A, Polverino E, Ewig S, Cillóniz C, Marcos M. A, Mensa J, ... and Torres A. Severity and outcomes of hospitalized community-acquired pneumonia in COPD patients. European Respiratory Journal. 2012;39(4):855-861. . ;:. PubMed Google Scholar
  29. Paul O, Lewis. Risk factor evaluation for methicilin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in community-acquired pneumonia. Ann Pharmacother. 2021;55:36-43. . ;:. PubMed Google Scholar
  30. Sando E, Suzuki M, Ishida M, Yaegashi M, Aoshima M, Ariyoshi K and Morimoto K. Definitive and indeterminate Pseudomonas aeruginosa infection in adults with community-acquired pneumonia: a prospective observational study. Annals of the American Thoracic Society. 2021;18(9):1475-1481. . ;:. PubMed Google Scholar
  31. Restrepo M. I, Babu B. L, Reyes L. F, Chalmers J. D, Soni N. J, Sibila O, ... and Aliberti S. Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalized patients. European Respiratory Journal. 2018;52(2). . ;:. PubMed Google Scholar
  32. Ko FW, Ip M, Chan Pk, Ng SS, Chan SS, Hui DS et al. A one-year prospective study of infectious etiology in patients hospitalized with acute exacerbaction of COPD and conmitant pneumonia. Respir Med 2008;102:1109-16. . ;:. PubMed Google Scholar
  33. Metlay JP, Waterer GW, Anzueto A, Long AC, Brozek J, Crothers K et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guidline of the American Thoracic Society and Infectious Diseases. Society of America. Am j Respir Crit care Med. 2019;200:e45-67. . ;:. PubMed Google Scholar
  34. Dueck N. P, Epstein S, Franquet T, Moore C. C and Bueno J. Atypical pneumonia: definition, causes, and imaging features. RadioGraphics. 2021;41(3):720-741. . ;:. PubMed Google Scholar
  35. Chaabane N, Coupez E, Buscot M and Souweine B. Acute respiratory distress syndrome related to Mycoplasma pneumoniae infection. Respiratory medicine case reports. 2017;20:89-91. . ;:. PubMed Google Scholar
  36. Tejada S, Romero A and Rello J. Community-Acquired Pneumonia in Adults: What's New Focusing on Epidemiology, Microorganisms and Diagnosis?. Erciyes Medical Journal/Erciyes Tip Dergisi. 2018;40(4):177-82. . ;:. Google Scholar


Author's Affiliation
Article Details

Issue: Vol 26 No 2 (2023)
Page No.: 2855-2862
Published: Jul 31, 2023
Section: Section: HEALTH SCIENCES
DOI: https://doi.org/10.32508/stdj.v26i2.4113

 Copyright Info

Creative Commons License

Copyright: The Authors. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 How to Cite
Ly, V., Ly, X., Le, H., & Pham, V. (2023). Bacterial pathogens causing community–acquired pneumonia in hospitalized adult patients with and without chronic obstructive pulmonary disease. Science and Technology Development Journal, 26(2), 2855-2862. https://doi.org/https://doi.org/10.32508/stdj.v26i2.4113


 Download Citation
 Cited by

Article level Metrics by Paperbuzz/Impactstory
Article level Metrics by Altmetrics

 Article Statistics
HTML = 1137 times
PDF   = 387 times
XML   = 0 times
Total   = 387 times